DaVita HealthCare Partners Inc. (NYSE:DVA) – Equities researchers at KeyCorp decreased their FY2018 earnings per share (EPS) estimates for DaVita HealthCare Partners in a note issued to investors on Tuesday. KeyCorp analyst J. Gurda now forecasts that the company will earn $3.58 per share for the year, down from their prior estimate of $3.90. KeyCorp has a “Hold” rating on the stock.

DaVita HealthCare Partners (NYSE:DVA) last posted its quarterly earnings data on Tuesday, August 1st. The company reported $0.92 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.02. DaVita HealthCare Partners had a return on equity of 14.02% and a net margin of 8.68%. The business had revenue of $3.88 billion for the quarter, compared to analyst estimates of $3.82 billion. During the same quarter in the prior year, the company earned $1.01 earnings per share. The company’s revenue was up 4.3% on a year-over-year basis. WARNING: This piece was posted by Watch List News and is the property of of Watch List News. If you are accessing this piece on another website, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The legal version of this piece can be accessed at https://www.watchlistnews.com/fy2018-eps-estimates-for-davita-healthcare-partners-inc-reduced-by-analyst-dva/1630202.html.

A number of other equities analysts have also weighed in on the stock. J P Morgan Chase & Co lowered shares of DaVita HealthCare Partners from a “neutral” rating to an “underweight” rating in a report on Monday, October 9th. Royal Bank Of Canada restated a “hold” rating and set a $64.00 target price on shares of DaVita HealthCare Partners in a report on Wednesday, September 6th. Zacks Investment Research lowered shares of DaVita HealthCare Partners from a “hold” rating to a “sell” rating in a report on Tuesday, July 4th. Jefferies Group LLC lowered shares of DaVita HealthCare Partners from a “buy” rating to a “hold” rating and lifted their target price for the company from $64.89 to $70.00 in a report on Monday, June 26th. Finally, BidaskClub lowered shares of DaVita HealthCare Partners from a “hold” rating to a “sell” rating in a report on Saturday, July 8th. Four research analysts have rated the stock with a sell rating, five have given a hold rating and one has given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $66.60.

Shares of DaVita HealthCare Partners (NYSE:DVA) opened at 54.73 on Thursday. DaVita HealthCare Partners has a 52-week low of $53.58 and a 52-week high of $70.16. The stock’s 50 day moving average price is $58.28 and its 200-day moving average price is $62.92. The stock has a market cap of $10.46 billion, a price-to-earnings ratio of 8.34 and a beta of 0.90.

Several large investors have recently bought and sold shares of the stock. Vanguard Group Inc. lifted its holdings in shares of DaVita HealthCare Partners by 2.2% during the 1st quarter. Vanguard Group Inc. now owns 15,080,919 shares of the company’s stock valued at $1,025,050,000 after acquiring an additional 331,482 shares in the last quarter. BlackRock Inc. lifted its holdings in shares of DaVita HealthCare Partners by 2,315.8% during the 1st quarter. BlackRock Inc. now owns 12,892,477 shares of the company’s stock valued at $876,303,000 after acquiring an additional 12,358,806 shares in the last quarter. State Street Corp lifted its holdings in shares of DaVita HealthCare Partners by 0.5% during the 1st quarter. State Street Corp now owns 7,533,514 shares of the company’s stock valued at $512,049,000 after acquiring an additional 38,416 shares in the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of DaVita HealthCare Partners by 14.4% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,879,322 shares of the company’s stock valued at $127,745,000 after acquiring an additional 236,224 shares in the last quarter. Finally, Park West Asset Management LLC lifted its holdings in shares of DaVita HealthCare Partners by 88.8% during the 1st quarter. Park West Asset Management LLC now owns 1,856,516 shares of the company’s stock valued at $126,187,000 after acquiring an additional 873,064 shares in the last quarter. Institutional investors and hedge funds own 83.27% of the company’s stock.

DaVita HealthCare Partners declared that its Board of Directors has approved a share repurchase program on Tuesday, October 10th that permits the company to repurchase $1.50 billion in outstanding shares. This repurchase authorization permits the company to buy shares of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s board of directors believes its stock is undervalued.

DaVita HealthCare Partners Company Profile

DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.

Earnings History and Estimates for DaVita HealthCare Partners (NYSE:DVA)

Receive News & Ratings for DaVita HealthCare Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita HealthCare Partners Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.